BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:46:32 AM | Browse: 774 | Download: 2197
Publication Name World Journal of Gastroenterology
Manuscript ID 84451
Country Italy
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
Manuscript Source Unsolicited Manuscript
All Author List Martina Crepaldi, Daria Maniero, Alessandro Massano, Margherita Pavanato, Brigida Barberio, Edoardo Vincenzo Savarino and Fabiana Zingone
ORCID
Author(s) ORCID Number
Martina Crepaldi http://orcid.org/0009-0008-8388-9699
Daria Maniero http://orcid.org/0000-0003-2468-7292
Alessandro Massano http://orcid.org/0000-0002-9064-3434
Margherita Pavanato http://orcid.org/0009-0009-9450-6582
Brigida Barberio http://orcid.org/0000-0002-3164-8243
Edoardo Vincenzo Savarino http://orcid.org/0000-0002-3187-2894
Fabiana Zingone http://orcid.org/0000-0003-1133-1502
Funding Agency and Grant Number
Corresponding Author Fabiana Zingone, MD, PhD, Assistant Professor, Doctor, Doctor, Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2 , Padua 35128, Italy. fabiana.zingone@unipd.it
Key Words Azathioprine; Inflammatory bowel diseases; Ulcerative Colitis; Crohn's Disease; Relapse; Side effects
Core Tip Prolonged use of azathioprine (AZA) remains controversial, and the time of interruption is uncertain. This retrospective study analyzed our single-center data of patients affected by inflammatory bowel disease who had started and then discontinued AZA between 1995 and 2022. AZA administration was effective and safe, and only 10% of patients who achieved remission with AZA needed a new treatment within 1 year of drug interruption.
Publish Date 2023-07-13 08:46
Citation Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343
URL https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm
DOI https://dx.doi.org/10.3748/wjg.v29.i27.4334
Full Article (PDF) WJG-29-4334-with-cover.pdf
Full Article (Word) WJG-29-4334.docx